1. Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    Nasreddine R, Florence E, Moutschen M, Yombi JC, Goffard JC, Derdelinckx I, Lacor P, Vandekerckhove L, Messiaen P, Vandecasteele S, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).J Med Virol. 2021 May;93(5):2971-2978. doi: 10.1002/jmv.26828. Epub 2021 Feb 9.PMID: 33506953 Free PMC article.
  2. Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.
    Nasreddine R, Florence E, Vandercam B, Moutschen M, Goffard JC, De Munter P, Delforge M, Marinus W, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).AIDS. 2020 Jul 1;34(8):1151-1159. doi: 10.1097/QAD.0000000000002533.PMID: 32287063
  3. Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.
    Van Beckhoven D, Florence E, De Wit S, Wyndham-Thomas C, Sasse A, Van Oyen H, Macq J; Belgian Research on AIDS, HIV Consortium (BREACH).HIV Med. 2020 Oct;21(9):557-566. doi: 10.1111/hiv.12901. Epub 2020 Jul 5.
  4. Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients.
    De Wit S, Florence E, Vandekerckhove L, Vandercam B, Goffard JC, Van Wijngaerden E, Moutschen M, Demeester R, Thilakarathne P, Piryns H; BREACH* Consortium.
    Acta Clin Belg. 2018 Oct;73(5):341-347. doi: 10.1080/17843286.2018.1458428. Epub 2018 Apr 6.
  5. Late presentation to HIV testing is overestimated when based on the consensus definition.
    Sasse A, Florence E, Pharris A, De Wit S, Lacor P, Van Beckhoven D, Deblonde J, Delforge ML, Fransen K, Goffard JC, Legrand JC, Moutschen M, Piérard D, Ruelle J, Vaira D, Vandercam B, Van Ranst M, Van Wijngaerden E, Vandekerckhove L, Verhofstede C; Belgian Research AIDS & HIV Consortium (BREACH).
    HIV Med. 2016 Mar;17(3):231-4. doi: 10.1111/hiv.12292. Epub 2015 Jul 28.
  6. Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.
    Van Beckhoven D, Florence E, Ruelle J, Deblonde J, Verhofstede C, Callens S, Vancutsem E, Lacor P, Demeester R, Goffard JC, Sasse A; BREACH Belgian Research on AIDS and HIV Consortium.
    BMC Infect Dis. 2015 Nov 3;15:496. doi: 10.1186/s12879-015-1230-3.


MediQuality Stephane De Wit BREACH 2016

La Ref Med BREACH 2017

Le Specialiste Les patients agés au coeur du debat BREACH 2017

Le Specialiste Prevention à personnes agées BREACH 2017

Ref Med diminution nombre diagnostics BREACH 2017

LeSpecialiste Le Sida en chiffres BREACH 2018

MediQuality Au dela des 3×90 BREACH Spring 2019

MediQuality Stephane De Wit CV indetectable qualité vieBREACH 2019

MediQuality Rakan N BREACH Sympo 2019

Experts advice Florence E Prise en charge du VIH Vision Belge

Le Specialiste BREACH 2019

VIH de la théorie au terrain De Wit S

Le ref Med Objectif 90 90 90 BREACH Spring 2021

Le Specialiste Besoins des PVVIH agees BREACH Sympo 2021

Le Specialiste Covid et VIH BREACH Sympo 2021

Le Specialiste Grossesse et VIH Allaitement BREACH Sympo 2021

Le Specialiste PrEP en Belgique BREACH Sympo 2021

Le specialiste VIH en 2020 BREACH 2021